Organovo Holdings Inc. (NASDAQ: ONVO)
$0.4460
+0.0150 ( -8.51% ) 107.7K
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Market Data
Open
$0.4460
Previous close
$0.4310
Volume
107.7K
Market cap
$6.62M
Day range
$0.4310 - $0.4870
52 week range
$0.3154 - $1.7400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Dec 31, 2024 |
| 8-k | 8K-related | 12 | Nov 22, 2024 |
| 10-q | Quarterly Reports | 65 | Nov 08, 2024 |
| ars | Annual reports | 1 | Oct 07, 2024 |
| def | Proxies and info statements | 21 | Oct 07, 2024 |
| pre | Proxies and info statements | 18 | Sep 18, 2024 |
| 8-k | 8K-related | 11 | Aug 09, 2024 |
| 4 | Insider transactions | 1 | Aug 09, 2024 |
| 4 | Insider transactions | 1 | Aug 09, 2024 |
| 4 | Insider transactions | 1 | Aug 09, 2024 |